Measles is one of the most contagious, vaccine-preventable viral infections, capable of infecting up to 90% of exposed nonimmune people. Respiratory droplets and aerosols from people infected with measles remain infectious for up to 2 hours. Infection in unvaccinated people can lead to hospitalization and death. Approximately 1 to 3 of every 1,000 children with measles will die from complications. Measles-mumps-rubella vaccination is highly safe and effective at reducing infection risk and preventing community spread. Population-based studies have found no association between vaccination and autism spectrum disorder or other neurodevelopmental disorders. Although measles has been considered eliminated in the United States since 2000, outbreaks have recently become larger and more common because vaccination rates in many states and counties have fallen below herd immunity thresholds. Symptoms include cough, coryza, conjunctivitis, and fever, followed by erythematous maculopapular exanthem. Family physicians play a key role in increasing vaccination rates and reducing risk of community spread through appropriate suspicion, early diagnostic testing, and isolation of people who are infected. Vitamin A supplementation may reduce mortality rates in hospitalized children with severe or complicated measles but should be used only under medical supervision to avoid toxicity; it should be avoided during pregnancy. Management of measles outbreaks requires isolating people who have been exposed or infected, discerning which people who were exposed have presumed immunity, and providing postexposure prophylaxis to nonimmune people with vaccination or immunoglobulin infusion.
Measles is caused by rubeola, a virus capable of infecting up to 90% of nonimmune people who have been exposed. Respiratory droplets and aerosols suspended in the air remain infectious for up to 2 hours.1 Infection rates have increased in recent years, and family physicians play a pivotal role in increasing vaccination rates and managing measles outbreaks. This review summarizes the epidemiologic trends and evidence for diagnosis, prevention, and treatment of measles.
SORT: KEY RECOMMENDATIONS FOR PRACTICE
| Clinical recommendation | Evidence rating | Comments |
|---|---|---|
| Measles-mumps-rubella vaccination is highly safe and the only effective way to prevent measles infections and complications in people 1 year and older who are not pregnant and are immunocompetent.7,9–14 | A | Large population-based outcome trials |
| Population-based studies have found no association between measles-mumps-rubella vaccination and autism spectrum disorder.9–14 | A | Large population-based outcome trials |
| Real-time polymerase chain reaction testing should be used to diagnose suspected measles infection and define outbreaks.23 | C | Small diagnostic accuracy studies |
| Appropriately dosed and medically supervised vitamin A supplementation may be used to reduce mortality risk in hospitalized children with severe or complicated measles. Unsupervised supplementation should be discouraged to avoid potential toxicity.24,29–32,34 | B | Meta-analysis of multiple studies performed outside the United States |
A = consistent, good-quality patient-oriented evidence; B = inconsistent or limited-quality patient-oriented evidence; C = consensus, disease-oriented evidence, usual practice, expert opinion, or case series. For information about the SORT evidence rating system, go to https://www.aafp.org/afpsort.
EPIDEMIOLOGY
- Before the vaccine was introduced in 1963, hundreds of measles deaths were reported annually in the United States, but by 2000, measles was considered eliminated nationwide.2,3 Measles outbreaks have been associated with international travel but since 2023 have become more common and widespread because of decreasing vaccination rates in many states and counties.2,4
- eFigure A shows numbers of confirmed infections by state, and Figure 1 shows vaccination rates for kindergartners by county.4 The number of measles cases in the United States increased from 285 in 2024 to 2,288 (with three confirmed deaths) in 2025.2 There have been 4,080 confirmed cases in 2026 as of October 9.2
- Approximately 1 to 3 of every 1,000 children with measles will die from complications.5
- The Centers for Disease Control and Prevention website and Johns Hopkins University measles tracker have the most up-to-date data on cases and vaccination rates.2,6 Table 1 lists online resources for tracking and managing outbreaks.
Read the full article
Get immediate access, anytime, anywhere.
Choose a single article, issue, or full-access subscription.
Earn up to 14 CME credits per issue.
